Results 51 to 60 of about 168,010 (264)
Bacterial polyphosphates interfere with the innate host defense to infection
Production of polyphosphate polymers is a ubiquitous trait of bacteria. Here, the authors investigate the role of bacterial long polyphosphates in host immune suppression and show that long polyphosphates produced by E.
Julian Roewe +12 more
doaj +1 more source
Commentary: Controversies in Thrombosis and Hemostasis Part 2-Does Sticky Platelet Syndrome Exist?
Controversies in Thrombosis and Hemostasis Part 2-Does Sticky Platelet Syndrome ...
Favaloro, Emmanuel J, Lippi, Giuseppe
core +1 more source
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
Quality in Laboratory Hemostasis and Thrombosis
2e (2010) ISBN 9781405169141 Federici: Von Willebrand Disease: Basic and Clinical Aspects, 1e (2011) ISBN 9781405195126 Ma: Hemophilia and Hemostasis: A Case Based Approach to Management, 2e (2012) ISBN ...
Preston, F. Eric +2 more
core
Cell‐Based Biohybrid Micro/Nanorobots for Biotherapy
This review systematically evaluates cell‐based biohybrid micro/nanorobots (CB‐BMRs), highlighting their cell selection criteria, fabrication strategies, and diverse actuation modes. Furthermore, it surveys the promising therapeutic applications of CB‐BMRs in targeted cancer, thrombosis, and inflammation treatments, while comprehensively discussing ...
Lin Wang +11 more
wiley +1 more source
Quality in hemostasis and thrombosis-part I.
Quality in hemostasis and thrombosis ...
Favaloro EJ, LIPPI, Giuseppe, Plebani M
core
This study develops an MMP‐9‐responsive protein release system that transforms resident cells into drug depots through in situ genetic engineering. Anchored to the membrane, the therapeutic protein TIMP1 is selectively released upon MMP‐9 cleavage.
Yuan Zhang +11 more
wiley +1 more source
Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the leading cause of treatment failure in high-risk acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), yet effective maintenance strategies are currently ...
Cuicui Lyu +6 more
doaj +1 more source

